We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£890.00
It has never been this cheap. We have no record of a lower price.
£890 today · cheaper than every other day in the last 2 months
2027-2032 World Outlook for Transitional Cell Bladder Cancer Therapeutics
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 4 days · 4 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 4 days • 1 price levels
Price Analysis
Most common price: £890 (4 days, 100.0%)
Price range: £890 - £890
Price levels: 1 different prices over 4 days
Description
Key Features
Covers transitional cell bladder cancer therapeutics market data for more than 190 countries across the 2027-2032 forecast period.
Provides latent demand and potential industry earnings (P.I.E.) estimates in millions of U.S. dollars for each country analysed.
Includes comparative benchmarks showing each country's percent share of regional and global therapeutic markets.
Utilises econometric models to project fundamental economic dynamics and generate reliable demand forecasts.
Published by ICON Group International, Inc., a recognised provider of global market intelligence and industry analysis.
Product Specifications
- Format
- paperback
- ASIN
- B0GR148BW2
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 05 January 2026
- Listed Since
- 03 March 2026
Similar Products You Might Like
The 2023-2028 World Outlook for Therapeutic Cancer Vaccines
The 2025-2030 World Outlook for Immuno-Oncology
The 2023-2028 World Outlook for Overactive Bladder Treatments
The 2023-2028 World Outlook for Endometrial Cancer Treatments
The 2027-2032 World Outlook for Peripheral Neuropathy Treatments
The 2027-2032 World Outlook for Bronchodilators
2026-2031 World Outlook for Biotherapeutics Cell Line Developments
2026-2031 World Outlook for Natural Killer Cell Therapeutics
The 2027-2032 World Outlook for Pain Management Therapeutics
The 2027-2032 World Outlook for Inhalation and Nasal Spray Drugs
The 2023-2028 World Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs
The 2023 Report on Hormone-Drug Breast Cancer Therapeutics: World Market Segmentation by City
The 2026-2031 World Outlook for Drug Repurposing
The 2026-2031 World Outlook for Drug Delivery across Blood Brain Barriers
The 2023-2028 World Outlook for Pharma Contract Sales
The 2023-2028 World Outlook for Irritable Bowel Syndrome Treatments
2027-2032 World Outlook for Angiogenesis Inhibitors and Stimulators
2027-2032 World Outlook for Community Acquired Pneumonia
The 2025-2030 World Outlook for Non-Melanoma Skin Cancers
The 2027-2032 World Outlook for Virology
The 2027-2032 World Outlook for Animal Pharmaceuticals
The 2026-2031 World Outlook for Anti-Smoking Drugs
The 2023-2028 World Outlook for Type 1 Spinal Muscular Atrophy